Sutron (STRN) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts STRN Hot Sheet
Price: $26.13 --0%
Financial Fact:
Research and development expenses: 825.77K
Today's EPS Names:
PKE, AMX, NP, More
Financial Fact:
Research and development expenses: 825.77K
Today's EPS Names:
PKE, AMX, NP, More
Join SI Premium – FREE
Sutron (NASDAQ: STRN) reported Q2 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $14.8 million versus the consensus estimate of $13.72 million.
For earnings history and earnings-related data on Sutron (STRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
- Telix Pharmaceuticals Limited (TLX) Reports Q2 results
- Wintrust Financial (WTFC) Tops Q2 EPS by 6c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
